Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Nonhematologic Malignancies × serabelisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1 Advanced Solid Tumor 1 Advanced Nonhematologic Malignancies 1

Interventions

sapanisertib 2 tovorafenib 1 serabelisib 1 pevonedistat 1 Paclitaxel 1 MLN 8237 1 Irinotecan 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01899053 2019-10-30

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

Takeda

Phase 1 Completed

101 enrolled 54 charts

Advanced Nonhematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡